Placenta
Volume 33, Issue 2 , Pages 81-87 , February 2012

Effects of iron deficiency anemia and its treatment with iron polymaltose complex in pregnant rats, their fetuses and placentas: Oxidative stress markers and pregnancy outcome

,Accepted 19 November 2011.

References 

  1. World Health Organization . Worldwide prevalance of anaemia 1993–2005: WHO global database on anaemia. 2008;
  2. Breymann C. Iron supplementation during pregnancy. Fetal Matern Med Rev. 2002;13:1–29
  3. Perewusnyk G, Huch R, Huch A, Breymann C. Parenteral iron therapy in obstetrics: 8 years experience with iron-sucrose complex. Br J Nutr. 2002;88:3–10
  4. Breymann C, Honegger C, Holzgreve W, Surbek D. Diagnosis and treatment of iron-deficiency anaemia during pregnancy and postpartum. Arch Gynecol Obstet. 2010;282:577–580
  5. Viteri FE. The consequences of iron deficiency and anaemia in pregnancy on maternal health, the foetus and the infant. SCN News. 1994;14–18
  6. Allen LH. Anemia and iron deficiency: effects on pregnancy outcome. Am J Clin Nutr. 2000;71:1280S–1284S
  7. Ren A, Wang J, Ye RW, Li S, Liu JM, Li Z. Low first-trimester hemoglobin and low birth weight, preterm birth and small for gestational age newborns. Int J Gynaecol Obstet. 2007;98:124–128
  8. Scholl TO. Iron status during pregnancy: setting the stage for mother and infant. Am J Clin Nutr. 2005;81:1218S–1222S
  9. Godfrey KM, Redman CW, Barker DJ, Osmond C. The effect of maternal anaemia and iron deficiency on the ratio of fetal weight to placental weight. Br J Obstet Gynaecol. 1991;98:886–891
  10. Bothwell TH. Iron requirements in pregnancy and strategies to meet them. Am J Clin Nutr. 2000;72:257S–264S
  11. Milman N. Prepartum anaemia: prevention and treatment. Ann Hematol. 2008;87:949–959
  12. Kawai K, Spiegelman D, Shankar AH, Fawzi WW. Maternal multiple micronutrient supplementation and pregnancy outcomes in developing countries: meta-analysis and meta-regression. Bull World Health Organ. 2011;89:402–411B
  13. Geisser P, Burckhardt S. The pharmacokinetics and pharmacodynamics of iron preparations. Pharmaceutics. 2011;3:12–33
  14. Heinrich HC, Gabbe EE, Whang DH. Dose dependency of the intestinal absorption of iron in humans with normal iron reserves and persons with prelatent-latent iron deficiency. Z Naturforsch B. 1969;24:1301–1310
  15. Dresow B, Petersen D, Fischer R, Nielsen P. Non-transferrin-bound iron in plasma following administration of oral iron drugs. Biometals. 2008;21:273–276
  16. Evans RW, Rafique R, Zarea A, Rapisarda C, Cammack R, Evans PJ, et al. Nature of non-transferrin-bound iron: studies on iron citrate complexes and thalassemic sera. J Biol Inorg Chem. 2008;13:57–74
  17. Casanueva E, Viteri FE. Iron and oxidative stress in pregnancy. J Nutr. 2003;133:1700S–1708S
  18. Kurtoglu E, Ugur A, Baltaci AK, Undar L. Effect of iron supplementation on oxidative stress and antioxidant status in iron-deficiency anemia. Biol Trace Elem Res. 2003;96:117–123
  19. Geisser P. Safety and efficacy of iron(III)-hydroxide polymaltose complex/A review of over 25 years experience. Arzneimittelforschung. 2007;57:439–452
  20. Toblli JE, Cao G, Olivieri L, Angerosa M. Comparison of the renal, cardiovascular and hepatic toxicity data of original intravenous iron compounds. Nephrol Dial Transplant. 2010;25:3631–3640
  21. Scholl TO, Hediger ML. Anemia and iron-deficiency anemia: compilation of data on pregnancy outcome. Am J Clin Nutr. 1994;59:492S–500S
  22. Crowe C, Dandekar P, Fox M, Dhingra K, Bennet L, Hanson MA. The effects of anaemia on heart, placenta and body weight, and blood pressure in fetal and neonatal rats. J Physiol. 1995;488(2):515–519
  23. Tojyo H. Effect of different intensities of iron-deficient anemia in pregnant rats on maternal tissue iron and fetal development. J Nutr Sci Vitaminol (Tokyo). 1983;29:339–351
  24. Mihaila C, Schramm J, Strathmann FG, Lee DL, Gelein RM, Luebke AE, et al. Identifying a window of vulnerability during fetal development in a maternal iron restriction model. PLoS One. 2011;6:e17483
  25. Gambling L, Andersen HS, Czopek A, Wojciak R, Krejpcio Z, McArdle HJ. Effect of timing of iron supplementation on maternal and neonatal growth and iron status of iron-deficient pregnant rats. J Physiol. 2004;561:195–203
  26. Knutson MD, Walter PB, Ames BN, Viteri FE. Both iron deficiency and daily iron supplements increase lipid peroxidation in rats. J Nutr. 2000;130:621–628
  27. Little RE, Gladen BC. Levels of lipid peroxides in uncomplicated pregnancy: a review of the literature. Reprod Toxicol. 1999;13:347–352
  28. Sugino N, Nakamura Y, Takeda O, Ishimatsu M, Kato H. Changes in activities of superoxide dismutase and lipid peroxide in corpus luteum during pregnancy in rats. J Reprod Fertil. 1993;97:347–351
  29. Allen LH. Biological mechanisms that might underlie iron’s effects on fetal growth and preterm birth. J Nutr. 2001;131:581S–589S
  30. Sakata M, Sado T, Kitanaka T, Naruse K, Noguchi T, Yoshida S, et al. Iron-dependent oxidative stress as a pathogenesis for preterm birth. Obstet Gynecol Surv. 2008;63:651–660
  31. Agarwal KN, Meenakshi K, Shah N, Susheela K. Placental morphological and biochemical studies in maternal anaemia before and after treatment. J Trop Pediatr. 1981;27:162–165
  32. Walter PB, Knutson MD, Paler-Martinez A, Lee S, Xu Y, Viteri FE, et al. Iron deficiency and iron excess damage mitochondria and mitochondrial DNA in rats. Proc Natl Acad Sci U S A. 2002;99:2264–2269
  33. Tiwari AKM, Mahdi AA, Zahra F, Chandyan S, Srivastava VK, Negi MPS. Evaluation of oxidative stress and antioxidant status in pregnant anemic women. Ind J Clin Biochem. 2010;25:411–418
  34. Kreuzer M, Kirchgessner M. Endogenous iron excretion. A quantitative means to control iron metabolism?. Biol Trace Elem Res. 1991;29:77–92
  35. Geisser P, Muller A. Pharmacokinetics of iron salts and ferric hydroxide-carbohydrate complexes. Arzneimittelforschung. 1987;37:100–104
  36. Gambling L, Charania Z, Hannah L, Antipatis C, Lea RG, McArdle HJ. Effect of iron deficiency on placental cytokine expression and fetal growth in the pregnant rat. Biol Reprod. 2002;66:516–523
  37. Hunt JS, Pace JL, Gill RM. Immunoregulatory molecules in human placentas: potential for diverse roles in pregnancy. Int J Dev Biol. 2010;54:457–467
  38. El-Bastawissi AY, Williams MA, Riley DE, Hitti J, Krieger JN. Amniotic fluid interleukin-6 and preterm delivery: a review. Obstet Gynecol. 2000;95:1056–1064
  39. Keelan JA, Mitchell MD. Placental cytokines and preeclampsia. Front Biosci. 2007;12:2706–2727
  40. Pantano C, Reynaert NL, van der Vliet A, Janssen-Heiniger YM. Redox-sensitive kinases of the nuclear factor-κB signaling pathway. Antioxid Redox Signal. 2006;8:1791–1806
  41. Lappas M, Permezel M, Georgiou HM, Rice GE. Nuclear factor κB regulation of proinflammatory cytokines in human gestational tissues in vitro. Biol Reprod. 2002;67:668–673
  42. Caniggia I, Mostachfi H, Winter J, Gassmann M, Lye SJ, Kuliszewski M, et al. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFβ3. J Clin Invest. 2000;105:577–587
  43. Tal R, Shaish A, Barshack I, Polak-Charcon S, Afek A, Volkov A, et al. Effects of hypoxia-inducible factor-1α overexpression in pregnant mice: possible implications for preeclampsia and intrauterine growth restriction. Am J Pathol. 2010;177:2950–2962
  44. Tangri S, Raghupathy R. Expression of cytokines in placentas of mice undergoing immunologically mediated spontaneous fetal resorptions. Biol Reprod. 1993;49:850–856
  45. Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol. 2005;3:28

PII: S0143-4004(11)00549-2

doi: 10.1016/j.placenta.2011.11.017

Placenta
Volume 33, Issue 2 , Pages 81-87 , February 2012

Article Tools

* Image Usage & Resolution